CRL
Charles River Laboratories International, Inc.
Healthcare
$158.86
as of May 21, 2026
Sign in to add CRL to your portfolio.
Sign inMarket cap
$7.52B
P/E (TTM)
-41.4x
EPS (TTM)
$-3.77
Dividend yield
—
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $3.54B | $390.98M | $532.03M | 37.7% | 16.7% | $7.77 |
| 2022 | $3.98B | $486.23M | $294.91M | 36.8% | 16.4% | $9.57 |
| 2023 | $4.13B | $474.62M | $365.37M | 36.4% | 14.9% | $9.27 |
| 2024 | $4.05B | $10.30M | $501.61M | 32.9% | 5.6% | $0.20 |
| 2025 | $4.02B | $-144.34M | $518.49M | 30.5% | 12.6% | $-2.91 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $155.06 | $158.86 | 594.44K |
| May 20, 2026 | $152.81 | $156.03 | 880.51K |
| May 19, 2026 | $150.59 | $152.43 | 1.09M |
| May 18, 2026 | $152.20 | $149.93 | 1.63M |
| May 15, 2026 | $157.54 | $150.85 | 1.40M |
| May 14, 2026 | $163.91 | $159.12 | 829.20K |
| May 13, 2026 | $167.04 | $162.85 | 735.00K |
| May 12, 2026 | $169.23 | $168.69 | 724.91K |
| May 11, 2026 | $176.97 | $168.46 | 762.30K |
| May 08, 2026 | $182.56 | $177.62 | 978.20K |
| May 07, 2026 | $189.30 | $181.68 | 1.34M |
| May 06, 2026 | $187.23 | $181.73 | 1.10M |
| May 05, 2026 | $174.68 | $185.39 | 1.17M |
| May 04, 2026 | $164.77 | $172.32 | 744.24K |
| May 01, 2026 | $167.66 | $165.78 | 668.80K |
| Apr 30, 2026 | $163.15 | $166.97 | 702.90K |
| Apr 29, 2026 | $167.06 | $163.84 | 532.36K |
| Apr 28, 2026 | $170.42 | $166.79 | 633.30K |
| Apr 27, 2026 | $170.06 | $171.23 | 750.62K |
| Apr 24, 2026 | $169.10 | $169.80 | 716.34K |
| Apr 23, 2026 | $178.65 | $167.74 | 1.24M |
| Apr 22, 2026 | $185.51 | $184.80 | 865.94K |
| Apr 21, 2026 | $186.18 | $183.10 | 445.01K |
| Apr 20, 2026 | $181.12 | $185.54 | 576.72K |
Profitability & balance
- ROE (TTM)
- -5.7%
- Gross margin
- 31.9%
- Operating margin
- 11.8%
- Net margin
- -4.6%
- Debt / equity
- 1.04